Group 1: Stock Performance - As of February 12, 2026, the stock price of the company closed at 12.97 yuan, down 0.31% for the day, with a cumulative increase of 0.39% over the past five days [1] - On February 11, 2026, the net outflow of main funds was 9.26 million yuan, accounting for 14.92% of the total transaction amount; on February 12, 2026, the net outflow continued at 6.76 million yuan, indicating a persistent outflow trend [1] - The trading volume decreased to 52.03 million yuan, with a turnover rate of 0.99%, reflecting a decline in market trading activity [1] Group 2: Shareholder Activity - From February 2 to 3, 2026, a major shareholder, Hong Kong Fengsheng Jiamei, reduced its holdings by 127,400 shares, cashing out approximately 1.60 million yuan, decreasing its shareholding from 5.03% to 5.00% [2] - Since July 2022, this shareholder has cumulatively reduced its holdings by 37.45 million shares, cashing out around 425 million yuan [2] - After the completion of the reduction plan, the remaining shares held by this shareholder amount to 20.56 million shares [2] Group 3: Financial Performance - The company's Q3 2025 report indicated a revenue of 451 million yuan for the first three quarters, representing a year-on-year growth of 32.04%, primarily driven by the ramp-up of new products in semiconductor optoelectronics and packaging testing [3] - However, the net profit attributable to the parent company was a loss of 81.77 million yuan, an increase in loss of 26.89% year-on-year, attributed to depreciation of new production lines, increased R&D investment, and high costs during the capacity ramp-up period [3] - In Q3 alone, revenue was 160 million yuan, a quarter-on-quarter increase of 13.60%, but the net profit loss was 31.31 million yuan, with a gross margin of 18.88% [3]

一、 信息披露义务人及其一致行动人的基本信息 1.身份类别 | | □控股股东/实际控制人及其一致行动人 | | --- | --- | | | 其他 5%以上大股东及其一致行动人 | | 投资者及其一致行动人的身份 | □合并口径第一大股东及其一致行动人（仅适用 | | | 于无控股股东、实际控制人） | | | □其他______________（请注明） | 2.信息披露义务人信息 证券代码：688079 证券简称：美迪凯 公告编号：2026-005 杭州美迪凯光电科技股份有限公司 关于持股 5%以上股东权益变动触及 5%刻度的提示性公告 股东香港豐盛佳美（國際）投資有限公司保证向本公司提供的信息真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 三、 其他说明 1、本次权益变动为 5%以上股东香港豐盛佳美（國際）投資有限公司履行 此前披露的减持股份计划，不触及要约收购。具体内容详见公司于 2026 年 1 月 12 日在上海证券交易所网站（www.sse.com.cn）披露的《杭州美迪凯光电科技 股份有限公司持股 5%以上股东 ...

杭州美迪凯光电科技股份有限公司 简式权益变动报告书 上市公司名称：杭州美迪凯光电科技股份有限公司 信息披露义务人：香港豐盛佳美（國際）投資有限公司 住所：香港九龙观塘海滨道133号万兆丰中心16楼F2室 通讯地址：香港九龍紅磡環海街11号海名轩三座65B 权益变动性质：股份减少，减少后持股比例触及5%刻度 签署日期：2026 年 2 月 3 日 1 上市地点：上海证券交易所 股票简称：美迪凯 股票代码：688079 信息披露义务人声明 本部分所述的词语或简称与本报告书"释义"部分所定义的词语或简称具有 相同的含义。 一、本报告书系依据《中华人民共和国公司法》《中华人民共和国证券法》 《上市公司收购管理办法》《公开发行证券的公司信息披露内容与格式准则第 15 号—权益变动报告书》等相关法律、法规和规范性文件编制。 二、依据《中华人民共和国证券法》《上市公司收购管理办法》的规定，本 报告书已全面披露了信息披露义务人在杭州美迪凯光电科技股份有限公司（以下 简称"美迪凯"、"上市公司"、"公司"）中拥有权益的股份变动情况。 截至本报告书出具日，除本报告书披露的信息外，信息披露义务人没有通过 任何其他方式增加或减少其在 ...

Core Viewpoint - The announcement indicates that Hong Kong Fengsheng Jiamei (International) Investment Co., Ltd., a major shareholder holding over 5% of the shares, has reduced its stake from 5.03% to 5.00% through a centralized bidding process, fulfilling a prior reduction plan without triggering a mandatory offer or changing the company's controlling shareholder or actual controller [1] Group 1 - The major shareholder reduced its holdings by 127,400 shares [1] - The reduction in shareholding percentage reached the 5% threshold [1] - The company will monitor the compliance of the shareholder's ongoing reduction plan and ensure timely information disclosure [1]

Group 1 - The core point of the article is that Medike (688079.SH) reported a change in shareholding by its major shareholder, Hong Kong Fengsheng Jiamei (International) Investment Co., Ltd., which reduced its stake from 5.03% to 5.00% [1] - The reduction involved the sale of 127,400 shares through the Shanghai Stock Exchange's centralized bidding system between February 2, 2026, and February 3, 2026 [1] - This change in equity holding triggered a notification as it touched the 5% threshold [1]

Market Performance - The optical optoelectronics sector increased by 3.37% on February 3, with Blue Special Optics leading the gains [1] - The Shanghai Composite Index closed at 4067.74, up 1.29%, while the Shenzhen Component Index closed at 14127.1, up 2.19% [1] Stock Highlights - Top performers in the optical optoelectronics sector included: - Blue Special Optics (688127) with a closing price of 49.51, up 14.05% and a trading volume of 174,400 shares, totaling 825 million yuan [1] - Geberka (920438) closed at 54.06, up 13.91% with a trading volume of 124,300 shares, totaling 634 million yuan [1] - MediKey (688079) closed at 13.24, up 11.45% with a trading volume of 144,900 shares, totaling 18.4 million yuan [1] - Dongtian Micro (301183) closed at 180.53, up 10.94% with a trading volume of 116,800 shares, totaling 2.034 billion yuan [1] - Qianzhao Optoelectronics (300102) closed at 42.40, up 10.33% with a trading volume of 1,702,700 shares, totaling 7.051 billion yuan [1] Fund Flow Analysis - The optical optoelectronics sector saw a net inflow of 727 million yuan from institutional investors, while retail investors experienced a net inflow of 238 million yuan [2] - Notable stock fund flows included: - Qianzhao Optoelectronics (300102) with a net inflow of 455 million yuan from institutional investors [3] - Geberka (920438) with a net inflow of 154 million yuan from institutional investors [3] - Dongtian Micro (301183) with a net inflow of 171 million yuan from institutional investors [3]

Group 1: Profit Forecasts - Dongcai Technology expects a net profit of approximately 300 million yuan for 2025, representing a year-on-year increase of about 65.73% [1] - Aerospace Electronics anticipates a net profit of 192 million to 247 million yuan for 2025, a decrease of 55% to 65% year-on-year [2] - Oulai New Materials forecasts a loss of 33 million to 48 million yuan for 2025, compared to a profit of 28.17 million yuan in the previous year [3] - Jiu Ding New Materials projects a net profit of 85 million to 98 million yuan for 2025, reflecting a year-on-year increase of 187.68% to 231.68% [5] - Chuan Yi Technology expects a net profit of 78 million to 103 million yuan for 2025, reversing a loss of 73.47 million yuan from the previous year [6] - Ju Yi Technology anticipates a net profit of 70 million to 105 million yuan for 2025, representing a year-on-year increase of 228.36% to 392.54% [7] - ST Xifa forecasts a net profit of 110 million to 160 million yuan for 2025, a year-on-year increase of 319.91% to 510.77% [19] - Light Media expects a net profit of approximately 1.5 billion to 1.9 billion yuan for 2025, reflecting a year-on-year increase of 413.67% to 550.65% [34] - Tianqi Lithium anticipates a profit of 369 million to 553 million yuan for 2025, compared to a loss of 7.905 billion yuan in the previous year [31] Group 2: Loss Forecasts - Star Ring Technology expects a loss of 220 million to 250 million yuan for 2025, with a projected revenue of 420 million to 450 million yuan, a year-on-year increase of 13.06% to 21.13% [9] - Filinger anticipates a loss of 65 million to 85 million yuan for 2025, compared to a loss of 37.31 million yuan in the previous year [10] - Jiahe Meikang forecasts a loss of 240 million to 280 million yuan for 2025, compared to a loss of 256 million yuan in the previous year [11] - Light Textile City expects a loss of 15 million to 22.5 million yuan for 2025 [23] - Ailon Technology anticipates a profit of 14.96 million to 22.44 million yuan for 2025, reversing a loss of 21.70 million yuan from the previous year [24] - ST Yun Chuang forecasts a loss of 139 million to 149 million yuan for 2025, with projected revenue of 53.5 million to 57.5 million yuan, a year-on-year increase of 6.15% to 14.09% [42] - Meike Home expects a loss of 1.2 billion to 1.8 billion yuan for 2025, compared to a loss of 864 million yuan in the previous year [36] Group 3: Shareholder Actions - Huafeng Chemical announced that shareholders plan to reduce their holdings by no more than 0.73% of the company's shares [8] - Naxinwei disclosed that shareholders plan to reduce their holdings by no more than 1.75% of the company's shares [12] - Shikong Technology announced that a shareholder plans to reduce their holdings by no more than 3% of the company's shares [13] - Yandong Micro disclosed that a shareholder plans to reduce their holdings by no more than 1% of the company's shares [37] - Daily Interaction announced that shareholders plan to reduce their holdings by no more than 0.135% of the company's shares [41]

Group 1: Transaction Overview - The company plans to introduce strategic investor Zhejiang Fuzhe Shaoxin Integrated Circuit Industry Fund Partnership (Limited Partnership) through its subsidiary Zhejiang Meidikai Optical Semiconductor Co., Ltd. [2] - The board of directors approved the proposal for capital increase and share expansion on December 10, 2025, and the relevant agreements have been signed [3]. Group 2: Transaction Progress - As of the announcement date, the company and related parties have signed the capital increase agreement and shareholder agreement, with a total cash capital increase of RMB 200 million received [3]. - Following the capital increase, the registered capital of the optical semiconductor company will increase from RMB 1,008,888,889 to RMB 1,101,447,503, and the company's shareholding will change to 82.44% [3]. Group 3: Performance Forecast - For the fiscal year 2025, the company expects to achieve approximately RMB 664.26 million in revenue, a year-on-year increase of 36.82% [8]. - The company anticipates a net loss attributable to shareholders of approximately RMB -154.41 million, a decrease of RMB 52.57 million compared to the previous year [8]. - EBITDA is projected to be around RMB 65.29 million, reflecting a year-on-year increase of 19.62% [8]. Group 4: Revenue Growth Factors - The revenue increase is attributed to higher sales in semiconductor packaging and testing, as well as new product launches contributing to additional revenue [14]. - Specific revenue contributions include an increase of approximately RMB 94.32 million from semiconductor packaging and testing and RMB 88.90 million from semiconductor acousto-optics [14]. Group 5: Cost and Expense Increases - The company has incurred higher costs due to stock incentive plans, increased interest expenses from larger borrowings, and rising depreciation costs from fixed asset investments [15][16]. - Research and development expenses have also increased, reflecting the company's commitment to new technologies and products [16].

Core Viewpoint - Meidike announced a projected loss for 2025 despite a revenue increase of approximately 6.64 billion yuan, marking a year-on-year growth of 36.82%. However, the net profit attributable to shareholders is expected to be around -1.54 billion yuan, worsening from -1.02 billion yuan in the previous year, with a non-recurring net profit of about -1.57 billion yuan, indicating a further decline in profitability [1]. Revenue and Business Performance - The revenue growth is attributed to the collaborative efforts across multiple business segments, with semiconductor packaging and testing sales expected to increase by 94.32 million yuan and semiconductor optoelectronics sales by 88.90 million yuan. Additionally, the company anticipates a revenue increase of 10.97 million yuan from the mass production of semiconductor process bonding prisms starting in November 2025, and 4.26 million yuan from small-scale production of MEMS devices [2]. Cost and Expense Analysis - The primary reason for the projected losses is attributed to rising costs and expenses. The company incurred approximately 43.21 million yuan in share-based payment expenses due to an equity incentive plan. Interest expenses rose to about 40.47 million yuan due to increased borrowing for substantial fixed asset investments. Depreciation expenses increased to approximately 205 million yuan, and labor costs rose to about 188 million yuan as projects entered mass production. Additionally, R&D expenses amounted to around 137 million yuan [2]. Client Relationships - Major downstream clients contributing significantly to the company's revenue include Huida Technology, Kyocera Group, and New Sound Semiconductor. The company has also established business partnerships with Canon, Nikon, AMS, Sunny Optical, Hikvision, Foxconn, Panasonic, Ricoh, Sony, AGC, and Keyence [3]. Future Development Directions - Looking ahead to 2026, the company has identified two core development directions. Firstly, it plans to increase R&D investment and production capacity for MEMS devices, particularly focusing on the industrialization of MicroLED and non-cooling infrared sensor chips, driven by the growing demand in humanoid robotics and AI sectors. Secondly, it aims to deepen its focus on the innovative intersection of semiconductors and optics, consolidating its core advantages in products like ultrasonic fingerprint recognition chips and image sensor optical layers [4]. Shareholder Actions - A significant shareholder, Hong Kong Fengsheng Jiamei (International) Investment Co., Ltd., plans to reduce its stake by up to 1% of the total share capital, approximately 4.11 million shares, starting from February 2, 2026. This shareholder has already reduced its holdings by about 12.20 million shares, representing 3% of the total share capital over the past 12 months [4].

Core Viewpoint - Medike (688079.SH) expects a significant increase in revenue for 2025, while net profit is projected to decline, indicating a mixed financial outlook for the company [1] Financial Projections - The company anticipates achieving an operating revenue of approximately 664.257 million yuan in 2025, representing an increase of about 178.746 million yuan or 36.82% year-on-year [1] - The projected net profit attributable to the parent company is expected to be around -154.414 million yuan, a decrease of approximately 52.568 million yuan compared to the previous year [1] - The net profit attributable to the parent company, after deducting non-recurring gains and losses, is estimated to be around -156.947 million yuan, reflecting a decline of about 63.860 million yuan year-on-year [1] Revenue Drivers - The increase in revenue is primarily driven by a rise in semiconductor packaging and testing sales, which are expected to increase by approximately 94.322 million yuan [1] - Sales from semiconductor acousto-optic products are projected to rise by about 88.898 million yuan [1] - The company will begin mass production and delivery of semiconductor process bonding prisms in November 2025, contributing an additional revenue of around 10.969 million yuan [1] - Small-scale production of MEMS devices (MicroLED, uncooled infrared) is expected to generate an increase in sales revenue of approximately 4.256 million yuan [1]